Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis

Abstract Invasive aspergillosis (IA) may occur as a serious complication of hematological malignancy. Delays in antifungal therapy can lead to an invasive disease resulting in high mortality. Currently, there are no well-established blood circulating microRNA biomarkers or laboratory tests which can...

Full description

Bibliographic Details
Main Authors: Gábor Fidler, Anna Anita Szilágyi-Rácz, Péter Dávid, Emese Tolnai, László Rejtő, Róbert Szász, Szilárd Póliska, Sándor Biró, Melinda Paholcsek
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-11239-z
_version_ 1818251161075974144
author Gábor Fidler
Anna Anita Szilágyi-Rácz
Péter Dávid
Emese Tolnai
László Rejtő
Róbert Szász
Szilárd Póliska
Sándor Biró
Melinda Paholcsek
author_facet Gábor Fidler
Anna Anita Szilágyi-Rácz
Péter Dávid
Emese Tolnai
László Rejtő
Róbert Szász
Szilárd Póliska
Sándor Biró
Melinda Paholcsek
author_sort Gábor Fidler
collection DOAJ
description Abstract Invasive aspergillosis (IA) may occur as a serious complication of hematological malignancy. Delays in antifungal therapy can lead to an invasive disease resulting in high mortality. Currently, there are no well-established blood circulating microRNA biomarkers or laboratory tests which can be used to diagnose IA. Therefore, we aimed to define dysregulated miRNAs in hematology and oncology (HO) patients to identify biomarkers predisposing disease. We performed an in-depth analysis of high-throughput small transcriptome sequencing data obtained from the whole blood samples of our study cohort of 50 participants including 26 high-risk HO patients and 24 controls. By integrating in silico bioinformatic analyses of small noncoding RNA data, 57 miRNAs exhibiting significant expression differences (P < 0.05) were identified between IA-infected patients and non-IA HO patients. Among these, we found 36 differentially expressed miRNAs (DEMs) irrespective of HO malignancy. Of the top ranked DEMs, we found 14 significantly deregulated miRNAs, whose expression levels were successfully quantified by qRT-PCR. MiRNA target prediction revealed the involvement of IA related miRNAs in the biological pathways of tumorigenesis, the cell cycle, the immune response, cell differentiation and apoptosis.
first_indexed 2024-12-12T16:03:53Z
format Article
id doaj.art-c4f5762d71c94ec7ba28c4a3341882c9
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-12T16:03:53Z
publishDate 2022-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c4f5762d71c94ec7ba28c4a3341882c92022-12-22T00:19:21ZengNature PortfolioScientific Reports2045-23222022-05-0112111710.1038/s41598-022-11239-zCirculating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosisGábor Fidler0Anna Anita Szilágyi-Rácz1Péter Dávid2Emese Tolnai3László Rejtő4Róbert Szász5Szilárd Póliska6Sándor Biró7Melinda Paholcsek8Department of Human Genetics, Faculty of Medicine, University of DebrecenDepartment of Human Genetics, Faculty of Medicine, University of DebrecenDepartment of Human Genetics, Faculty of Medicine, University of DebrecenDepartment of Human Genetics, Faculty of Medicine, University of DebrecenDepartment of Hematology, Jósa András Teaching HospitalDivision of Hematology, Institute of Internal Medicine, Faculty of Medicine, University of DebrecenDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of DebrecenDepartment of Human Genetics, Faculty of Medicine, University of DebrecenDepartment of Human Genetics, Faculty of Medicine, University of DebrecenAbstract Invasive aspergillosis (IA) may occur as a serious complication of hematological malignancy. Delays in antifungal therapy can lead to an invasive disease resulting in high mortality. Currently, there are no well-established blood circulating microRNA biomarkers or laboratory tests which can be used to diagnose IA. Therefore, we aimed to define dysregulated miRNAs in hematology and oncology (HO) patients to identify biomarkers predisposing disease. We performed an in-depth analysis of high-throughput small transcriptome sequencing data obtained from the whole blood samples of our study cohort of 50 participants including 26 high-risk HO patients and 24 controls. By integrating in silico bioinformatic analyses of small noncoding RNA data, 57 miRNAs exhibiting significant expression differences (P < 0.05) were identified between IA-infected patients and non-IA HO patients. Among these, we found 36 differentially expressed miRNAs (DEMs) irrespective of HO malignancy. Of the top ranked DEMs, we found 14 significantly deregulated miRNAs, whose expression levels were successfully quantified by qRT-PCR. MiRNA target prediction revealed the involvement of IA related miRNAs in the biological pathways of tumorigenesis, the cell cycle, the immune response, cell differentiation and apoptosis.https://doi.org/10.1038/s41598-022-11239-z
spellingShingle Gábor Fidler
Anna Anita Szilágyi-Rácz
Péter Dávid
Emese Tolnai
László Rejtő
Róbert Szász
Szilárd Póliska
Sándor Biró
Melinda Paholcsek
Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
Scientific Reports
title Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
title_full Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
title_fullStr Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
title_full_unstemmed Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
title_short Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
title_sort circulating microrna sequencing revealed mirnome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
url https://doi.org/10.1038/s41598-022-11239-z
work_keys_str_mv AT gaborfidler circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT annaanitaszilagyiracz circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT peterdavid circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT emesetolnai circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT laszlorejto circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT robertszasz circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT szilardpoliska circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT sandorbiro circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis
AT melindapaholcsek circulatingmicrornasequencingrevealedmirnomepatternsinhematologyandoncologypatientsaidingtheprognosisofinvasiveaspergillosis